Skip to content

BL, 04.1 MM RC, SLACTIVE 8MM, TIZR AND 10MM, 12, 14MM SLActive Roxolid BL (REF 021.4312)Recalls & reported problems

Institut Straumann AG · Bone Level Implant D 4.1mm RC, SLActive® 12mm, Roxolid® Loxim™ · Class 2 · Implant

All models of BL, 04.1 MM RC, SLACTIVE 8MM, TIZR AND 10MM, 12, 14MM (14)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Quick summary

This Straumann Bone Level implant is placed in the jawbone. The reports mostly describe implants that did not bond with the bone, with some also mentioning pain, infection or tissue damage. FDA records list 5,324 reports, no deaths, 5,324 injuries and no malfunction reports. No recalls name this device.

AI-generated from the FDA records on this page and checked automatically against the numbers below. Read the details before relying on it.

Adverse event reports
5,339
Deaths reported
0
Injuries reported
5,339
Recalls naming it
0

Summary

The FDA's MAUDE database contains 5,339 adverse event reports that list this exact device (DI 07630031706874), received between Sep 9, 2019 and Sep 28, 2026 — classified as 5,339 injuries.

The most frequently reported specific device problem is “Failure to Osseointegrate” (3,312 reports).

1 other recall cover devices cleared under the same FDA submission (K121131); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 72 reportsDec 2023: 46 reportsJan 2024: 40 reportsFeb 2024: 39 reportsMar 2024: 56 reportsApr 2024: 88 reportsMay 2024: 66 reportsJun 2024: 54 reportsJul 2024: 64 reportsAug 2024: 56 reportsSep 2024: 53 reportsOct 2024: 58 reportsNov 2024: 83 reportsDec 2024: 29 reportsJan 2025: 61 reportsFeb 2025: 50 reportsMar 2025: 45 reportsApr 2025: 28 reportsMay 2025: 0 reportsJun 2025: 155 reportsJul 2025: 38 reportsAug 2025: 73 reportsSep 2025: 27 reportsOct 2025: 49 reportsNov 2025: 41 reportsDec 2025: 61 reportsJan 2026: 58 reportsFeb 2026: 38 reportsMar 2026: 48 reportsApr 2026: 37 reportsMay 2026: 49 reportsJun 2026: 41 reportsJul 2026: 45 reportsAug 2026: 29 reportsSep 2026: 26 reportsOct 2026: 0 reports202420252026155
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Failure to Osseointegrate3,312
  • Loss of Osseointegration1,409
  • Adverse Event Without Identified Device or Use Problem463
  • Fracture84
  • Difficult to Insert78
  • Difficult to Remove10
  • Separation Failure5
  • Therapeutic or Diagnostic Output Failure4

Patient problems

  • No Clinical Signs, Symptoms or Conditions1,730
  • Fibrosis1,524
  • Pain1,146
  • Unspecified Infection949
  • Tissue Damage838
  • Inflammation587
  • Hemorrhage/Blood Loss/Bleeding323
  • Swelling/ Edema320

Recent adverse event reports

The 25 most recent of 5,339 reports, in the reporter's own words as published by the FDA.

  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50922021 ↗
  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50921885 ↗
  • InjurySep 28, 2026Loss of Osseointegration

    Patient problems: Pain

    MAUDE report 50921578 ↗
  • InjurySep 28, 2026Loss of Osseointegration

    Patient problems: Fibrosis

    MAUDE report 50921179 ↗
  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: Fibrosis

    MAUDE report 50921079 ↗
  • InjurySep 18, 2026Failure to Osseointegrate

    Patient problems: Hyperresponsive to stimuli

    MAUDE report 50826509 ↗
  • InjurySep 18, 2026Loss of Osseointegration

    Patient problems: Fibrosis

    MAUDE report 50824705 ↗
  • InjurySep 18, 2026Loss of Osseointegration

    Patient problems: Fibrosis; Pain

    MAUDE report 50824702 ↗
  • InjurySep 18, 2026Loss of Osseointegration

    The clinician reports the implant was inserted (B)(6) 2026 in ADA 8. Details of surgery: Ridge augmentation. On (B)(6) 2026, loss of osseointegration was verified. No product was returned to the manufacturer. At the event the patient experienced: Mobility. No further patient complications were reported.

    Patient problems: Fibrosis

    MAUDE report 50823881 ↗
  • InjurySep 18, 2026Loss of Osseointegration

    Patient problems: Fibrosis; Pain

    MAUDE report 50823876 ↗
  • InjurySep 17, 2026Failure to Osseointegrate

    Patient problems: Fibrosis

    MAUDE report 50807816 ↗
  • InjurySep 17, 2026Adverse Event Without Identified Device or Use Problem

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50807680 ↗
  • InjurySep 17, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50807202 ↗
  • InjurySep 17, 2026Adverse Event Without Identified Device or Use Problem

    The clinician reports that the day the implant was placed in ADA 5, failure occurred upon insertion. Details of surgery: Primary stability not achieved, Implant surface not completely covered with bone and Immediate extraction site. Patient presented with bone type III. The device was forwarded to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50806439 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50760287 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50760282 ↗
  • InjurySep 11, 2026Failure to Osseointegrate

    Patient problems: Hyperresponsive to stimuli; Inflammation

    MAUDE report 50738111 ↗
  • InjurySep 11, 2026Loss of Osseointegration

    Patient problems: Fibrosis

    MAUDE report 50738092 ↗
  • InjurySep 10, 2026Loss of Osseointegration

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50719529 ↗
  • InjurySep 10, 2026Loss of Osseointegration

    The clinician reports the implant was inserted (b)(6) 2020 in ADA 13. On 2026-08-03, loss of osseointegration was verified. The device was forwarded to the manufacturer. There were no patient operative or post-operative complications reported.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50719183 ↗
  • InjurySep 10, 2026Loss of Osseointegration

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50719181 ↗
  • InjurySep 10, 2026Loss of Osseointegration

    The clinician reports the implant was inserted 2020 (b)(6) in ADA 13. On 2026 (b)(6), loss of osseointegration was verified. The device was forwarded to the manufacturer. There were no patient operative or post-operative complications reported.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50718617 ↗
  • InjurySep 10, 2026Loss of Osseointegration

    The clinician reports the implant was inserted (b)(6) 2020 in ADA 6. On (b)(6) 2026, loss of osseointegration was verified. The device was forwarded to the manufacturer. There were no patient operative or post-operative complications reported.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50718583 ↗
  • InjurySep 7, 2026Loss of Osseointegration

    Patient problems: Fibrosis

    MAUDE report 50655107 ↗
  • InjurySep 7, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50654701 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K121131. One submission often covers many models, so check the product and lot details in each record.

  • Z-0174-2015 · Sep 24, 2014 · Terminated
    Straumann Bone Level Implant 04.1 mm RC, SLActive 8mm, Roxolid, Loxim Article Number: 021.4308 Product Usage: Dental implants are intended for surgical placement in maxillary and/

Other IMPLANT, ENDOSSEOUS, ROOT-FORM devices

All IMPLANT, ENDOSSEOUS, ROOT-FORM devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page